Atrophy of the alveolar crest with reduced bone width and height is a challenging limitation for dental implant placement. In these cases, additional surgical procedures could be necessary to augment the insufficient bone volume. However, these augmentation procedures are cost- and time-intensive and could lead to morbidity and postoperative complications. In addition, in medically compromised patients augmentation procedures may carry a higher risk of complications. Therefore, the focus of clinical and scientific research is increasingly on alternative concepts such as narrow diameter implants (NDI). At the 6th ITI Consensus Conference, NDI were defined as implants with a diameter ≤ 3.5 mm. This general classification does not give full consideration to the different clinical indications for NDI. Therefore, NDI were divided into the following three categories:
- Category 1: Implants with a diameter of < 2.5 mm (“mini-implants”)
- Category 2: Implants with a diameter of 2.5 mm to 3.3 mm
- Category 3: Implants with a diameter of 3.3 mm to 3.5 mm
Promising survival rates have been published for all 3 groups. However, long-term evaluation of clinical success rates is rare. NDI will not be replacing standard-diameter implants any time soon due to their challenging handling. New indications for NDI like the highly atrophic edentulous jaw or the small tooth gap are opening up. In addition, they offer dental implant treatment for medically compromised patients. Therefore, NDI are a promising extension of implant treatment options, but they will not turn complex implant cases into easy cases.